BRCA1 and neoplasm: In order to assess whether a complete loss of BRCA1 underpinned tumor development in patient 1 and explained the BRCA1 promoter methylation above 0.50 detected in the tumor tissue, the loss of heterozygosity (LOH) at chromosome 17 was investigated.